HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SOFTMEDX-NEW

0.380

0.000

Volume:- -

Turnover:- -

Market Cap:123.89M

PE:- -

High:0.380

Open:0.380

Low:0.380

Close:0.380

52wk High:0.380

52wk Low:0.380

Shares:326.04M

HK Float Shares:326.04M

Volume Ratio:1.77

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:0.81

PE(LYR):- -

PS:- -

Loading ...

Overview Company News Filings

Concept

Suspected Financial Misconduct+1.27%

Capital Flow

Inflow:

Outflow:

News

SOFTMEDX-NEW (00648): Independent Non-Executive Director Tang Cuihuan Appointed to Remuneration Committee, Nomination Committee and Risk Management Committee

SoftMedx Healthcare Returns to Profit in H1

MT Newswires Live

SOFTMEDX-NEW (00648) Reports Interim Results with Profit Attributable to Shareholders of HK$3.353 Million, Turning from Loss to Profit

SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/00648"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00648","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00648\",,,,,undefined,":{"symbol":"00648","market":"HK","secType":"STK","nameCN":"SOFTMEDX-NEW","latestPrice":0.38,"timestamp":1756430409413,"preClose":0.38,"halted":3,"volume":0,"delay":0,"floatShares":326036828,"shares":326036828,"eps":0,"marketStatus":"Halted","change":0,"latestTime":"08-29 09:20:09","open":0.38,"high":0.38,"low":0.38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756690200000},"marketStatusCode":7,"adr":0,"listingDate":657129600000,"exchange":"SEHK","adjPreClose":0.38,"openAndCloseTimeList":[[1756431000000,1756440000000],[1756443600000,1756454400000]],"volumeRatio":1.7730159632735405,"lotSize":5000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00648\",,,,,undefined,":{"symbol":"00648","floatShares":326036828,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.7730159632735405,"shares":326036828,"dividePrice":0,"high":0.38,"amplitude":0,"preClose":0.38,"low":0.38,"week52Low":0.38,"pbRate":"0.81","week52High":0.38,"institutionHeld":0,"latestPrice":0.38,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0.38,"prevYearClose":0.44,"prevWeekClose":0.44,"prevMonthClose":0.44,"prevQuarterClose":0.44,"fiveDayClose":0.44,"twentyDayClose":0.44,"sixtyDayClose":0.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00648\",params:#limit:5,,,undefined,":[{"date":"2025-08-18","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-25","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"","dateTimestamp":1742832000000,"actualEps":null},{"date":"2024-08-30","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null},{"date":"2024-03-27","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-05-19","symbol":"00648","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1684459800000,"name":null,"time":"","dateTimestamp":1684425600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00648\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00648\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00648\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167803600","title":"SOFTMEDX-NEW (00648): Independent Non-Executive Director Tang Cuihuan Appointed to Remuneration Committee, Nomination Committee and Risk Management Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1167803600","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167803600?lang=en_us&edition=fundamental","pubTime":"2025-08-19 21:26","pubTimestamp":1755609975,"startTime":"0","endTime":"0","summary":"SOFTMEDX-NEW (00648) announced that Ms. Tang Cuihuan, an independent non-executive director, has been appointed as a member of the company's Remuneration Committee, Nomination Committee and Risk Management Committee, effective from August 19, 2025.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1511","00648"],"gpt_icon":0},{"id":"2560156573","title":"SoftMedx Healthcare Returns to Profit in H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2560156573","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560156573?lang=en_us&edition=fundamental","pubTime":"2025-08-19 11:07","pubTimestamp":1755572860,"startTime":"0","endTime":"0","summary":"SoftMedx Healthcare  reported HK$3.4 million in attributable profit for the half ended June 30, reversing a loss of HK$6.1 million in the prior-year period, according to a Monday filing with the Hong Kong bourse.Earnings per share were HK$0.01, compared with a loss of HK$0.019 in the prior year.Revenue rose 17% year-on-year to HK$35.8 million, figures showed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1511","00648","HCSG","BK4137"],"gpt_icon":0},{"id":"1172138641","title":"SOFTMEDX-NEW (00648) Reports Interim Results with Profit Attributable to Shareholders of HK$3.353 Million, Turning from Loss to Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1172138641","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172138641?lang=en_us&edition=fundamental","pubTime":"2025-08-18 20:04","pubTimestamp":1755518682,"startTime":"0","endTime":"0","summary":"SOFTMEDX-NEW (00648) announced its interim results for 2025, reporting revenue of HK$35.771 million, representing a 16.5% increase year-on-year. Profit attributable to shareholders reached HK$3.353...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648","BK1511"],"gpt_icon":0},{"id":"2552482692","title":"SoftMedx Healthcare Limited Publishes Audited Financial Results for FY2024, Revealing 6.4% Revenue Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482692","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552482692?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:53","pubTimestamp":1752760421,"startTime":"0","endTime":"0","summary":"SoftMedx Healthcare Limited has published its audited financial results for the year ended 31 December 2024. The company reported a 6.4% increase in revenue, reaching HK$54.6 million, compared to HK$51.3 million in the previous year. This growth was primarily driven by the company's efforts to expand its product offerings by obtaining new product sources. Despite facing challenges from shifting consumer preferences and competitive market conditions, SoftMedx managed to increase its sales volume and maintain its market position. The company continues to focus on leveraging its industry expertise and customer relationships to deliver high-quality healthcare products and services. Trading in the company's shares remains suspended pending the fulfillment of resumption conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informationa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL9hHHgx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/00648\",params:#limit:6,delay:false,,,undefined,":[{"market":"HK","name":"Suspected Financial Misconduct","bkCode":"BK1511","id":"package_hk_concept_yscjg","changeRate":0.012694}]}}